San Holdings,inc. (9628 JT) Stock Price Quote, News &…

Summary

SAN Holdings, Inc. is a Japanese company that specializes in providing funeral services. The firm manages a network of approximately 70 funeral establishments across the country. Established in 1932, its corporate headquarters are situated in Tokyo, Japan.

Website

www.san-hd.co.jp

Location

Tokyo, CO, JP

Phone81 3 5770 3301

Employees709

CEOSatoshi Harishima

Sector

Industrials

Industry

Commercial Services & Supplies

IPO DateJan 9, 2001

Ask AI

Company overview

Business model, segments, and competition.

Peer comparison

Metrics vs closest competitors.

Guidance & outlook

Forward guidance and assumptions.

Bull vs bear case

Upside drivers and key risks.

Valuation snapshot

Multiples vs history and peers.

Competitive moat

Defensibility and market position.

Management track record

Leadership and capital allocation history.

Latest Documents

Mentions in Filings

As of June 30, 2026, the Company had the following operating subsidiaries: HH Processors, LLC, IGC Pharma IP, LLC, IGC Pharma, LLC, SAN Holdings, LLC, Hamsa Biopharma India Pvt. Ltd., and Colombia-based beneficially owned subsidiary IGC Pharma SAS. The Company’s fiscal year ends on December 31. The Company’s principal office is in Maryland, and it is a Maryland corporation established in 2005. Additionally, the Company has offices in Colombia, So …
IGC Pharma, Inc.San Holdings,inc.·10-Q - Quarterly report Q2·Q2 26·14 Aug
#Sala Corp. 60,261 432,445 Samco, Inc., Class D 3,200 98,846 San Holdings, Inc. 8,200 78,779
Dimensional ETF TrustSan Holdings,inc.·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
… Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public. Item C.1. Identification of investment. a. Name of issuer (if any). SAN HOLDINGS,INC. b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series. N/A c. Title of the issue or description of the investment. SAN HOLDINGS INC d. CU …
Dimensional ETF TrustSan Holdings,inc.·NPORT-P - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
Beyond IGC-AD1, our development pipeline includes additional early-stage therapeutic candidates targeting Alzheimer’s disease mechanisms, including **TGR-63** and other investigational compounds currently in preclinical evaluation. These programs are intended to expand our long-term development portfolio while maintaining a disciplined focus on clinical execution and capital efficiency. The Company is also developing **MINT-AD**, a proprietary, …
IGC Pharma, Inc.San Holdings,inc.·10-Q - Quarterly report Q1·Q1 26·15 May
… tinue to incur operating losses as we advance our clinical and research programs. As of December 31, 2025, the Company had the following operating subsidiaries: HH Processors, LLC, IGC Pharma IP, LLC, IGC Pharma, LLC, SAN Holdings, LLC, Hamsa Biopharma India Pvt. Ltd., and Colombia-based beneficially owned subsidiary IGC Pharma SAS. During the nine months ended December 31, 2025, the Company shut down a few of its non-operating subsidiaries, whi …
IGC Pharma, Inc.San Holdings,inc.·10-KT - Transition report (annual) FY 2025·FY25·18 Mar
As of November 13, 2025, the Company had the following direct operating subsidiaries: Techni Bharathi Private Limited (TBL), HH Processors, LLC, IGC Pharma IP, LLC, IGC Pharma, LLC, SAN Holdings, LLC, Hamsa Biopharma India Pvt. Ltd. and Colombia-based beneficially owned subsidiary IGC Pharma SAS. The Company’s fiscal year is the 52- or 53-week period that ends on March 31. The Company’s principal office is in Maryland, established in 2005. Additi …
IGC Pharma, Inc.San Holdings,inc.·S-8 - Registration statement (employee benefit plan)·Q3 26·14 Nov 2025

Key Stats

Trading

Px/Chg 1D$1,292.00 / -0.54%

Avg Volume48.46K

Beta0.05

Mkt Cap30.56B

FD Mkt Cap32.07B

Float

Shrs Out/Float23.65M / 17.58M

Short Float0.00%

Days to Cover0.00

Stock Repurchased$0.00

Current Valuation

EV35.84B

EV/EBITDA6.03

EV/Sales0.95

P/B0.68

P/S0.81

FCF Yield0.00%

ROE1.56%

ROA0.98%

Current Ratio1.73

Dividend

Ex-Dividend DateAug 28, 2026

Cash (Aug 28, 2026)$28.00

Yield (Aug 28, 2026)4.18%

Yield (TTM)4.18%

Estimates

P/E6.79

Est P/EN/A

Est EPSN/A

Est PEGN/A

Valuation

Metric	5Yr Avg	Jun '22	Jun '23	Jun '24	Jun '25	Oct '26
PRICE-BASED RATIOS
Price / Earnings	8.04	5.15	8.24	10.33	6.63	9.82
Price / Sales	1.34	0.53	1.06	1.09	0.98	3.04
Price / Book Value	0.67	0.35	0.73	0.74	0.84	0.68
Price / Free Cash Flow	7.31	6.40	9.24	10.96	9.96	0.00
ENTERPRISE VALUE METRICS
Enterprise Value	20,918.8	3,417.1	14,000.3	14,887.7	36,444.7	35,844.1
Enterprise Value / Sales	1.24	0.17	0.65	0.66	1.14	3.56
Enterprise Value / EBITDA	7.57	0.80	2.95	3.15	5.72	25.21
Enterprise Value / EBIT	13.79	1.01	3.63	3.93	8.06	52.33

Financials

Full Financials

Millions JPY	5Yr CAGR (%)	Mar '22	Mar '23	Mar '24	Mar '25	Mar '26
INCOME STATEMENT
Revenue	17.3%	20,001.0	21,663.0	22,437.0	31,984.0	37,865.0
Gross Income	6.2%	4,704.0	5,297.0	5,247.0	7,182.0	5,984.0
EBITDA	8.8%	4,245.0	4,743.0	4,725.0	6,377.0	5,943.0
EBIT	-1.9%	3,377.0	3,861.0	3,784.0	4,522.0	3,125.0
Net Income	21.9%	2,040.0	2,783.0	2,363.0	4,721.0	4,500.0
EPS (Diluted)	22.8%	93.79	131.90	114.37	230.96	213.37
BALANCE SHEET
Cash & ST Inv	8.8%	7,443.0	9,192.0	9,789.0	12,663.0	10,442.0
Total Assets	22.2%	34,037.0	36,422.0	37,780.0	63,588.0	76,015.0
Total Liabilities	62.9%	4,405.0	4,804.0	4,901.0	26,415.0	30,991.0
Total Shareholder Equity	11%	29,629.0	31,615.0	32,877.0	37,172.0	45,021.0
CASH FLOW
Net Operating Cash Flow	21.4%	2,991.0	3,262.0	3,170.0	5,345.0	—
Cap Ex	17.7%	-1,349.0	-780.0	-942.0	-2,201.0	—
Free Cash Flow	24.2%	1,642.0	2,482.0	2,228.0	3,144.0	—

San Holdings,inc.(9628 JT)

Financials & Metrics